Clinical Trials and Results The TRIUMPH-1 Phase 3 clinical trial results are pivotal in assessing Retatrutide's potential
Appetite remains suppressed, but without the accompanying gastrointestinal distress that made eating difficult during month 2
These are your best options
Some common challenges include: In a medical study, adults living with obesity, or with overweight and at least one weight-related medical problem, who took Wegovy pill, along with a reduced-calorie diet and increased physical activity, lost on average about 33 lb, which was about 14% of their starting body weight
For this drug, the ongoing SOUL trial has shown promising preliminary results, indicating a 14% reduction in the risk of MACE (84)
Mounjaro (Tirzepatide) A new class of GLP-1 medication that provides dual benefits for both diabetes and weight loss is of particular importance in people who do not necessarily have diabetes